All News #Library
Biotech
Fresenius Kabi Secures Permanent Q-Code For Conexxence®
29 Sep 2025 //
BUSINESSWIRE
Polpharma Bio and Fresenius Sign Licensing Agreement fo PB016
13 Aug 2025 //
BUSINESSWIRE
mAbxience`s Denosumab Biosimilars Approved by European Commission
02 Jul 2025 //
PR NEWSWIRE
Ori Biotech, Fresenius Collaborate On Gene Therapy Manufacturing
10 Dec 2024 //
GLOBENEWSWIRE
CMS Grants Fresenius Kabi Q-Code and Payment Status for Tyenne®
29 Oct 2024 //
BUSINESSWIRE
Fresenius Kabi and Cellular Origins Collaborate on CGT Automation
16 Oct 2024 //
CONTRACTPHARMA
Cellular Origins And Fresenius Kabi Sign Agreement For Gene Therapy
16 Oct 2024 //
BUSINESSWIRE
Fresenius & Formycon Receive FDA Approval For Biosimilar Otulfi
30 Sep 2024 //
BUSINESSWIRE

Market Place
Sourcing Support